Literature DB >> 31949856

miR-196 acts as a tumor suppressor in osteosarcoma by targeting HOXA9.

Yang Cao1, Binqi Wu1, Dawei Wang1, Zhenggang Bi1.   

Abstract

Abnormal expression of microRNAs (miRNAs) has been found in most cancer types. Therefore, the discovery of miRNAs could help us to understand the mechanism of tumor initiation and development. The purpose of this study was to investigate the significance of miR-196 in osteosarcoma (OS) and to identify its target genes. We found miR-196 expression was significantly reduced in OS tissues and cell lines (Saos-2 and MG-63) as compared to normal tissues and cell line. The OS cell line proliferation and migration abilities were inhibited by miR-196 overexpression but promoted by miR-196 downregulation in vitro. Moreover, we revealed that miR-196 could bind to the 3'-untranslated region (3'-UTR) of homeobox A9 (HOXA9) and inhibit HOXA9 expression in OS cell lines. Furthermore, knockdown the expression of HOXA9 resulted in decreased proliferation and migration which was similar to that observed with miR-196 overexpression in OS cell lines. In summary, miR-196 inhibits proliferation and migration of OS cell lines through regulating HOXA9, which might be a useful target for OS treatment. IJCEP
Copyright © 2018.

Entities:  

Keywords:  HOXA9; miR-196; osteosarcoma; tumor suppressor

Year:  2018        PMID: 31949856      PMCID: PMC6962975     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  23 in total

1.  Evolution of microRNAs located within Hox gene clusters.

Authors:  Andrea Tanzer; Chris T Amemiya; Chang-Bae Kim; Peter F Stadler
Journal:  J Exp Zool B Mol Dev Evol       Date:  2005-01-15       Impact factor: 2.656

Review 2.  Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

Authors:  Witold Filipowicz; Suvendra N Bhattacharyya; Nahum Sonenberg
Journal:  Nat Rev Genet       Date:  2008-02       Impact factor: 53.242

Review 3.  Perspectives in targeting miRNA function.

Authors:  Christiane Schöniger; Christoph Arenz
Journal:  Bioorg Med Chem       Date:  2013-04-02       Impact factor: 3.641

Review 4.  Current concepts on the molecular biology of osteosarcoma.

Authors:  Richard Gorlick
Journal:  Cancer Treat Res       Date:  2009

Review 5.  Epigenetics and genetics. MicroRNAs en route to the clinic: progress in validating and targeting microRNAs for cancer therapy.

Authors:  Andrea L Kasinski; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2011-11-24       Impact factor: 60.716

Review 6.  Future directions in the treatment of osteosarcoma.

Authors:  Michael W Bishop; Katherine A Janeway; Richard Gorlick
Journal:  Curr Opin Pediatr       Date:  2016-02       Impact factor: 2.856

7.  MiR-196a exerts its oncogenic effect in glioblastoma multiforme by inhibition of IκBα both in vitro and in vivo.

Authors:  Guang Yang; Dayong Han; Xin Chen; Daming Zhang; Lu Wang; Chen Shi; Weiguang Zhang; Chenguang Li; Xiaofeng Chen; Huailei Liu; Dongzhi Zhang; Jianhao Kang; Fei Peng; Ziyi Liu; Jiping Qi; Xin Gao; Jing Ai; Changbin Shi; Shiguang Zhao
Journal:  Neuro Oncol       Date:  2014-01-23       Impact factor: 12.300

Review 8.  HOX genes and their role in the development of human cancers.

Authors:  Seema Bhatlekar; Jeremy Z Fields; Bruce M Boman
Journal:  J Mol Med (Berl)       Date:  2014-07-05       Impact factor: 4.599

Review 9.  Oncomirs - microRNAs with a role in cancer.

Authors:  Aurora Esquela-Kerscher; Frank J Slack
Journal:  Nat Rev Cancer       Date:  2006-04       Impact factor: 60.716

Review 10.  New molecular insights into osteosarcoma targeted therapy.

Authors:  Jilong Yang; Wei Zhang
Journal:  Curr Opin Oncol       Date:  2013-07       Impact factor: 3.645

View more
  3 in total

1.  miR-140 and miR-196a as Potential Biomarkers in Breast Cancer Patients.

Authors:  Arman Shahabi; Behrooz Naghili; Khalil Ansarin; Vahid Montazeri; Nosratollah Zarghami
Journal:  Asian Pac J Cancer Prev       Date:  2020-07-01

2.  Phenytoin Inhibits Cell Proliferation through microRNA-196a-5p in Mouse Lip Mesenchymal Cells.

Authors:  Hiroki Yoshioka; Sai Shankar Ramakrishnan; Akiko Suzuki; Junichi Iwata
Journal:  Int J Mol Sci       Date:  2021-02-09       Impact factor: 5.923

3.  Molecular features and vulnerabilities of recurrent chordomas.

Authors:  Carolin Seeling; André Lechel; Michael Svinarenko; Peter Möller; Thomas F E Barth; Kevin Mellert
Journal:  J Exp Clin Cancer Res       Date:  2021-07-30
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.